Halladay Benjamin 4
4 · Esperion Therapeutics, Inc. · Filed Apr 21, 2025
Insider Transaction Report
Form 4
Halladay Benjamin
Chief Financial Officer
Transactions
- Sale
Common Stock
2025-04-17$0.96/sh−8$8→ 481,702 total
Footnotes (1)
- [F1]Shares were sold to satisfy tax obligation on vested shares of restricted stock units.